BTSA Biotecnologías Aplicadas SL
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
BTSA Biotecnologías Aplicadas SL - overview
Established
1994
Location
Madrid, -, Spain
Primary Industry
Food
About
Based in Madrid, Spain, and founded by Ana Ugidos Álvarez in 1994, BTSA Biotecnologías Aplicadas SL operates as a manufacturer and seller of natural antioxidants and natural vitamin E. The company sells its products to food, nutraceutical, cosmetics & personal care, pharmaceutical, and animal nutrition industries in France and in more than 40 countries worldwide. In December 2022, the firm’s majority stakes were acquired by ABAC Capital. BTSA as of December 2022, employs 56 employees in its commercial office in Chicago, US, and sales offices in Mexico and Brazil.
The company develops and manufactures a range of natural and semi-natural antioxidants based on tocopherols and mixtures of different origins like sunflower origin, soy origin, etc. , and natural Vitamin E from non-GMO vegetable oil. Some of the brands under which the firm sells its products include Tocobiol, Nutrabiol T, Ecoflax, etc in feeding, Tocobiol C, Bioxan T, etc in cosmetics, and Oxabiol, Ecoflax Feed, Omega Tech Feed, etc in animal nutrition. BTSA as of December 2022, has a turnover of USD 20 million.
The December 2022 acquisition will support the firm’s development of new solutions and its expansion in new markets.
Current Investors
Abac Capital
Primary Industry
Food
Sub Industries
Snack Foods
Website
http://www.btsa.com
Verticals
Manufacturing
Company Stage
Mature - Buyout
Total Amount Raised
Subscriber access only
BTSA Biotecnologías Aplicadas SL - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Buyout | Completed | BTSA Biotecnologías Aplicadas SL | - |
Displaying 1 - 1 of 1
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.